Selective .beta.3 adrenergic agonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 231/18 (2006.01) A61K 31/415 (2006.01)

Patent

CA 2312849

The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and methods of treating Type II diabetes and obesity, comprising administering to a mammal in need thereof compounds of formula (I) or a pharmaceutically acceptable salt thereof. The variables of formula (I) have the meanings defined herein.

La présente invention concerne le domaine médical, et plus particulièrement le traitement du diabète de type II et de l'obésité. Plus spécifiquement, cette invention concerne des agonistes du récepteur .beta.¿3? utilisés dans le traitement des diabètes de type II et de l'obésité. Cette invention concerne par ailleurs des composés et des procédés permettant de traiter les diabètes de type II et l'obésité, consistant à administrer à un mammifère souffrant de ces troubles les composés représentés par la formule (I), ou un sel de ceux-ci pharmaceutiquement acceptable. Les variables de la formule (I) sont telles que définies précédemment.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Selective .beta.3 adrenergic agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Selective .beta.3 adrenergic agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective .beta.3 adrenergic agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2055285

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.